ロード中...

A randomised, double-blind, parallel-group trial to assess mercaptopurine versus placebo to prevent or delay recurrence of Crohn’s disease following surgical resection (TOPPIC)

Background: Crohn’s disease (CD) is a chronic, relapsing, inflammatory bowel disease. Up to 65% of patients with CD require an operation to control the disease within 10 years. Both endoscopic and clinical recurrence is common within 2 years of operation, with re-operation rates cumulating at 5% of...

詳細記述

保存先:
書誌詳細
主要な著者: Jack Satsangi, Nicholas A Kennedy, Craig Mowat, Ian Arnott, Catriona Keerie, Steff Lewis, Holly Ennis
フォーマット: Artigo
言語:Inglês
出版事項: NIHR Journals Library 2017-09-01
シリーズ:Efficacy and Mechanism Evaluation
主題:
オンライン・アクセス:https://doi.org/10.3310/eme04040
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!